Researchers at Case Western Reserve University have developed a treatment for advanced prostate cancer that could eliminate a ...

SAN FRANCISCO -- Almost 80% of patients with heavily pretreated advanced/metastatic pancreatic cancer achieved disease ...

A study led by researchers at Moffitt Cancer Center found that normal cells surrounding a tumor, known as cancer-associated ...

From new imaging and targeted therapies to patient journeys, 2025 highlighted key advances and personal stories in lung ...

The FDA designates ARB1002 as an orphan drug, highlighting its potential as a novel treatment for pancreatic cancer amid ...

SAN FRANCISCO -- Including encorafenib (Braftovi) and cetuximab (Erbitux) in the first-line treatment of BRAF V600E-mutated ...

A recently published study found that targeted radiation delivered before surgery can eradicate certain early-stage ...

Colon cancer treatment is personalized based on stage, overall health and tumor characteristics. Early detection and accurate ...

The Alliance for Clinical Trials in Oncology has launched a randomized phase III clinical trial called RECIPROCAL (Alliance ...

A research team at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) has developed a radiopharmaceutical molecule marker that ...

An expert discusses how long-term safety considerations are evaluated through clinical trial data and postmarketing surveillance, emphasizing the importance of reporting unexpected adverse events to ...

MIT researchers have developed an experimental mRNA-based therapy that restored key immune functions lost with age in mice.